Contrast sensitivity as an outcome measure in patients with subfoveal choroidal neovascularisation due to age-related macular degeneration.
about
Evaluation of contrast sensitivity and other visual function outcomes in neovascular age-related macular degeneration patients after treatment switch to aflibercept from ranibizumab.Luminance noise as a novel approach for measuring contrast sensitivity within the magnocellular and parvocellular pathwaysPredicting visual outcomes for macular disease using optical coherence tomography.Cost-Effectiveness Models in Age-Related Macular Degeneration: Issues and Challenges.Visual Function and Its Relationship with Severity of Early, and Activity of Neovascular, Age-Related Macular DegenerationDiabetes-induced impairment in visual function in mice: contributions of p38 MAPK, rage, leukocytes, and aldose reductase.Topical dorzolamide for treatment of cystoid macular edema in patients with choroideremia.Visual performance in patients with neovascular age-related macular degeneration undergoing treatment with intravitreal ranibizumab.Video monitoring of neovessel occlusion induced by photodynamic therapy with verteporfin (Visudyne), in the CAM model.Retinal-image quality and contrast-sensitivity function in age-related macular degeneration.Baseline clinical measures and early response predict success in verteporfin photodynamic therapy for neovascular age-related macular degeneration.Clinical applicability of the Macular Degeneration Detection Device (MDD-2): a novel photostress recovery measurement device.The introduction of verteporfin photodynamic therapy in the UK: PDT users group (PDTUG) surveillance programme report 1.The SPARCS: a novel assessment of contrast sensitivity and its reliability in patients with corrected refractive error.The reading accessibility index and quality of reading grid of patients with central vision loss.Fixational eye movements predict visual sensitivity.Characterization of Visual Function, Interocular Variability and Progression Using Static Perimetry-Derived Metrics in RPGR-Associated Retinopathy.
P2860
Q33596886-E636DD9B-4F78-48F1-9055-E7557B799BF5Q33873120-93B05FBF-7261-410C-8454-79E518AC38A6Q38130239-3EBC71AA-A686-4695-B036-5FF475DBAF72Q38631993-4C034444-E87D-450F-AC75-CADC4E246F84Q38837386-10BBF00D-442C-4CA5-85BE-DF6E976294D3Q39238006-79ED2C95-E57B-43C9-9FA8-0ECC520734F2Q39791335-6D6D2B3E-1F5F-4948-80ED-64241AC0C3F5Q41206130-64BB1790-837E-4C96-B9A1-B3C8240CDDA8Q41278020-2D27F17C-3EBA-4218-9E08-4ACA0370FFCBQ42951402-8EF1104B-7211-4347-AE43-C0315A6CB49AQ43193898-0B0B8324-A0B1-4981-8026-97AD34EC5874Q46433854-526AEF84-C22C-43AF-B9CD-1BA28C5FDBD6Q47579315-A0328FA2-E423-4201-B966-C67F435B8E9BQ47858714-D77F6F91-22A0-4601-8ECC-740ABEF166A7Q50424244-977417F3-C585-4738-9614-5D69E7EB9C45Q51002377-CDC9E082-F5E9-4C34-88CC-D97C4619DD49Q55114372-0182D689-55BB-499E-98A2-DDA6A089029D
P2860
Contrast sensitivity as an outcome measure in patients with subfoveal choroidal neovascularisation due to age-related macular degeneration.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Contrast sensitivity as an out ...... -related macular degeneration.
@ast
Contrast sensitivity as an out ...... -related macular degeneration.
@en
type
label
Contrast sensitivity as an out ...... -related macular degeneration.
@ast
Contrast sensitivity as an out ...... -related macular degeneration.
@en
prefLabel
Contrast sensitivity as an out ...... -related macular degeneration.
@ast
Contrast sensitivity as an out ...... -related macular degeneration.
@en
P2860
P356
P1433
P1476
Contrast sensitivity as an out ...... -related macular degeneration.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.EYE.6701717
P577
2005-11-01T00:00:00Z
P5875
P6179
1028483150